Emily Littlejohn (@ELittlejohnDO) header
Emily Littlejohn (@ELittlejohnDO) profile picture

Director, Lupus Clinic 🦋@ClevelandClinic Associate Professor of Medicine @CCLCM

Cleveland, OH
Joined March 2015
Photo by Emily Littlejohn (@ELittlejohnDO)Photo by Emily Littlejohn (@ELittlejohnDO)Photo by Emily Littlejohn (@ELittlejohnDO)Photo by Emily Littlejohn (@ELittlejohnDO)Photo by Emily Littlejohn (@ELittlejohnDO)Photo by Emily Littlejohn (@ELittlejohnDO)Photo by Emily Littlejohn (@ELittlejohnDO)Photo by Emily Littlejohn (@ELittlejohnDO)Photo by Emily Littlejohn (@ELittlejohnDO)Photo by Emily Littlejohn (@ELittlejohnDO)
Emily Littlejohn retweeted
NEXT STEPS: Karp and investigators are engaged in the MONA LISA study - Using smile Data and biospeciments – they intend to look for biomarkers that may better predict the future development of SLE Dr. David Karp lecturing at UTSW @drdavidkarp @utswrheum
8
11
717
Emily Littlejohn retweeted
REcently published SMILE study looked at the potential of HCQ (vs PBO) to prevent SLE in at risk people. Had to be ANA+ and 1-2 SLICC criteria at entry. Can you Prevent SLE? Dr. David Karp lecturing at UTSW @drdavidkarp @utswrheum
19
3
40
4,854
To our patients with autoimmune diseases asking about the benefits of GLP-1s; the anti inflammatory effects are beyond those of weight loss alone ⬇️ @CleClinicMD
6
809
Rheuminating on new material for the podcast @HRheuminations @AdamJBrownMD #ACR2025
11
1,329
The mentors who raised me 💙 #GoBlue #acr25
3
503
Emily Littlejohn retweeted
‼️More reasons why we should avoid steroids in #lupus patients @RheumNow #APLAR25
3
11
1
25
2,188
Emily Littlejohn retweeted
IMPACT Study - Certolizumab Efficacy in APS Pregnancies A pilot trial assessed the safety and value of tumour necrosis factor α inhibitor treatment with certolizumab in patients with high-risk pregnancies with antiphospholipid syndrome (APS). Certolizumab (CZP) was shown to reduced the risk of adverse pregnancy outcomes (APOs) in high-risk patients with APS. buff.ly/2qMUTs5
8
1
27
1,842
Emily Littlejohn retweeted
✅ In-depth knowledge of the interpretation of #antinuclear antibody (#ANA) testing is KEY for the diagnosis of #autoimmune diseases such as #Lupus. Nice talk at #lupus2025 @LupusCongress Toronto by May Choi about the use of ML to profile ANA images 👍
75
3
189
14,612
To all our lupus warriors, we’re routing for you 💜
1
2
24
732
Emily Littlejohn retweeted
Dr M Petri touts the benefits of HCQ- she has caveats: get an OCT at 5 years, if in rare instances the pt develops heart failure, get an endomyocardial biopsy #CCRE25
4
16
72
5,137
Emily Littlejohn retweeted
A myriad of cardiovascular complications in SLE patients . Need for cardiorheumaology ⁦@ELittlejohnDO⁩ ⁦@CCF_IMCHIEFS⁩ ⁦@CleClinicHVTI⁩ ⁦@ACCinTouch⁩
3
22
969
🗣️ “Every day that goes by we feel more comfortable using the word #remission in #lupus,” Dr. @ELittlejohnDO @ClevelandClinic. See more from the #BusyClinician special series on CAR-T. ⬇️ bit.ly/4boqYea
1
6
581
Join our LIVE GLOBAL TOWN HALL w Georg Schett & @MaxKonigMD - the latest data on the theory and practice of CAR-T Rx for #autoimmunity - registration FREE - 2 hrs & our news letter x 1 yr- Designed for the busy clinician!! @ELittlejohnDO @AdamJBrownMD ccfcme.org/Clinical25
1
3
2
1,015